
Apple owes a $300 million lump sum for infringing wireless standard-essential patents owned by IP management company Optis Wireless Technology and its affiliates, a federal jury in an East Texas federal court said Friday after a four-day trial.
A jury ruled last year in the same case that Apple owed $506 million for infringing Plano, Texas-based Optis, PanOptis Patent Management, and Unwired Planet’s LTE patents with technology found in its iPhone and other LTE-capable products. U.S. District Judge Rodney Gilstrap ordered a new trial in his Marshall, Texas, court in April, after finding the award may not have been in line with Optis’ responsibility to license the patents on fair, reasonable and non-discriminatory (FRAND) terms.
“We thank the jury for their time but are disappointed by the verdict and plan to appeal,” Apple spokesperson Josh Rosenstock said in an email. “Optis makes no products and its sole business is to sue companies using patents they accumulate. We will continue to defend against their attempts to extract unreasonable payments.”
Apple’s attorney Mark Selwyn of Wilmer Cutler Pickering Hale & Dorr didn’t immediately respond to a request for comment, nor did Optis and its attorneys Jason Sheasby and Annita Zhong of Irell & Manella.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas